Epiterna (private company)
See something wrong or missing? Let us know
Offices:Lausanne
Industry:Health servicesManufacturingPharma
Business model:B2B
Epiterna is a Swiss health startup working on a high-throughput drug screening platform used for drug evaluation and effect assessment on healthy lifespan, ultimately leading developing products slowing the ageing process and preventing age-related disease, delaying functional decline, and life extension.
Investors:
we tracked 1 investor
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 10.58M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Epiterna
Name | Criteria | |
---|---|---|
![]() |
Ability Pharma
58%
|
|
![]() |
Beckley Psytech
58%
|
|
![]() |
Curida
58%
|
|
![]() |
Baseimmune
58%
|
|
![]() |
Cytoki Pharma
58%
|
|
![]() |
Harg
58%
|
|
![]() |
Abalos Therapeutics
58%
|
|
![]() |
Emergence Therapeutics
58%
|
|
![]() |
Oncorena
58%
|
|
![]() |
SafeHeal
58%
|
|